rs822336 Binding to C/EBPβ and NFIC Modulates Induction of PD-L1 Expression and Predicts Anti-PD-1/PD-L1 Therapy in Advanced NSCLC

Researchers validated the predictive value of PD-L1 single nucleotide polymorphisms (SNPs) in advanced NSCLC patients treated with immune checkpoint inhibitors as well as to define the molecular mechanisms underlying the role of the identified SNP candidate.
[Molecular Cancer]
Full Article